en

PRODUCT DETAIL

Respreeza 4 000 mg prášok a rozpúšťadlo na infúzny roztok.

Code 0920D
MA number EU/1/15/1006/002
Product Form: plv fol 1x4000 mg + 1x76 ml solv. (liek.inj.skl.)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
Therapeutic Class: 16 - ANTICOAGULANTIA (FIBRINOLYTICA, ANTIFIBRINOL.)
ATC:
B BLOOD AND BLOOD FORMING ORGANS
B02 ANTIHEMORRHAGICS
B02A ANTIFIBRINOLYTICS
B02AB Proteinase inhibitors
B02AB02 Alfa1 antitrypsin
Shelf life: 24
Container: glass vial
Route of admin.: Intravenous use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 8(3) application - known active substance
MA issued: 20.08.2015
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 11.05.2020
eu-flag.png sk-flag.png